0.50Open0.50Pre Close0 Volume3 Open Interest35.00Strike Price0.00Turnover201.85%IV115.41%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier27DDays to Expiry0.50Extrinsic Value100Contract SizeAmericanOptions Type0.1364Delta0.0242Gamma32.96Leverage Ratio-0.0367Theta0.0013Rho4.49Eff Leverage0.0098Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet